Skip to main content

Our objective

Research undertaken within our Group is focused on determining the mechanisms underlying clot formation in healthy individuals; applying this knowledge to better understand the mechanisms leading to platelet hyperactivity and pathological blood clot formation; and ultimately development of safer and more effective therapies to treat cardiovascular diseases, including heart attack, stroke, diabetes and the metabolic syndrome.

The team